Kopin Corporation (KOPN) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance with a significant turnaround in net income, reduced SG&A expenses, and a robust cash position. Product development and strategic partnerships, such as with Theon International, indicate potential for future growth. Although there are some uncertainties, like the exact timeline for automation benefits and European orders, the overall sentiment is positive due to the optimistic guidance for future programs and the strategic focus on high-demand sectors like defense and medical.
Key Financial Performance
Total Revenues (Q3 2025) $12 million, a decrease from $13.3 million in Q3 2024 (-9.8%). The decline was attributed to reduced revenues from products used in pilot helmets and training and simulation, partially offset by increased sales from products used in thermal weapon sights.
Product Revenues (Q3 2025) $10.7 million, a slight decrease from $10.9 million in Q3 2024 (-1.8%). The decrease was primarily due to lower revenues from pilot helmets and training and simulation products, offset by higher sales of thermal weapon sight products.
Funded Research and Development Revenues (Q3 2025) $1.2 million, a significant decrease from $2.3 million in Q3 2024 (-47.8%). This was due to the timing of completed projects and a shift in focus to programs moved to production.
Cost of Product Revenue (Q3 2025) $8.4 million (79% of net product revenues), compared to $8.3 million (76% of net product revenues) in Q3 2024. The increase was due to higher manufacturing costs for training and simulation products and 3D AOI products, partially offset by improved efficiency in making thermal weapon sight products.
R&D Expenses (Q3 2025) $2.5 million, a decrease of $0.1 million from Q3 2024 (-3.8%). The reduction was due to decreased spending on U.S. defense programs as programs transitioned from development to production.
SG&A Expenses (Q3 2025) $1.6 million, a significant decrease from $5.2 million in Q3 2024 (-69.2%). The decrease was primarily due to reduced accrued legal expenses, partially offset by an increase in noncash stock compensation.
Net Income (Q3 2025) $4.1 million ($0.02 per share), compared to a net loss of $3.5 million ($0.03 per share) in Q3 2024. The improvement was largely due to a $5.1 million add-back for a reduction in litigation accruals.
Net Cash Used in Operating Activities (First 9 months of 2025) $7.7 million. No year-over-year comparison provided.
Cash Position (End of Q3 2025) $26.5 million, not significantly different from the prior quarter. However, subsequent to Q3, the company raised $41 million from strategic and institutional investors and completed a $15 million transaction with an individual strategic investor, significantly improving the cash position.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Microdisplays and optical technologies: Kopin has partnered with Theon International to integrate their microdisplays and optical technologies into night vision and thermal imaging systems for defense and security applications.
Drone and UAV market: Kopin's microdisplay products are aligned with the growing drone and UAV market, supported by partnerships with companies like Unusual Machines and Ondas Holdings.
Color microLED: Kopin announced a $15.4 million award to develop a sovereign-built color microLED for U.S. Army applications, including daytime AR and weapon-sight platforms.
Defense and security: Kopin is targeting increased defense budgets and modernization efforts globally, particularly in Europe, Southeast Asia, and NATO countries.
Drone market growth: The first-person drone market is projected to grow from under $300 million to $1.2 billion by 2030, with a compound annual growth rate of 31%.
Manufacturing quality improvements: Kopin has resolved quality issues in its manufacturing facilities, achieving some of the highest quality scores in its history.
Financial stability: The company raised $41 million from strategic and institutional investors and completed a $15 million transaction with an individual investor, significantly improving its cash position.
Strategic partnerships: Kopin has entered into partnerships with global organizations like Theon International, Ondas Holdings, and Unusual Machines to expand its market reach and product applications.
Focus on defense technologies: Kopin is concentrating on defense technologies, including thermal weapon sights, aviation heads-up displays, and armored vehicle applications, to align with evolving military needs.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Demand for products: Potential risks include fluctuations in demand for Kopin's products, which could adversely impact revenue and operational stability.
Operating results of subsidiaries: Uncertainties in the performance of subsidiaries could negatively affect the company's consolidated financial results.
Market conditions: Adverse market conditions, including economic uncertainties and geopolitical tensions, could impact the company's growth and profitability.
Regulatory hurdles: Compliance with U.S. and international defense regulations and potential changes in these regulations could pose challenges to operations and strategic objectives.
Supply chain disruptions: Dependence on suppliers for manufacturing components could lead to disruptions, affecting production timelines and costs.
Litigation risks: The company faces ongoing legal challenges, including a legacy lawsuit in Colorado, which could result in financial liabilities and distract management from strategic priorities.
Cost of production: Higher manufacturing costs for certain products, such as training and simulation products, could reduce profit margins.
R&D funding fluctuations: Decreased funded research and development revenues due to timing of completed projects and transitions to production could impact innovation and future growth.
Geopolitical tensions: Increasing geopolitical tensions could lead to both opportunities and risks, including potential disruptions in international markets and supply chains.
Strategic execution risks: Challenges in executing strategic partnerships and scaling production capacity could hinder the company's ability to meet growth objectives.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Defense Market Growth: Increased defense budgets and the need for enhanced situational awareness in nighttime and daytime operations, border security, and counterterrorism missions are driving significant growth expectations, particularly in Europe, Southeast Asia, and NATO countries. Kopin and Theon International aim to capitalize on these trends.
Drone Market Expansion: The first-person drone market is projected to grow from under $300 million in 2024 to $1.2 billion by 2030, representing a compound annual growth rate of 31%. Kopin's microdisplay products are well-positioned to capture demand in this rapidly expanding market.
U.S. Army Drone Procurement: The U.S. Army plans to purchase at least 1 million drones over the next 2-3 years, with potential annual acquisitions reaching millions. Kopin's microdisplay technologies are aligned with this demand.
SBMC Program Opportunity: The Soldier Borne Mission Command (SBMC) program, a $22 billion U.S. Army initiative, is expected to award production contracts in 2027. Kopin is positioned to supply critical technologies for this program.
Revenue and Profitability Goals: Kopin is confident in achieving its revenue and profitability targets for 2027 and 2028, supported by a strong pipeline of opportunities and long-term program contracts.
Geopolitical Tensions and Defense Spending: Increasing geopolitical tensions are expected to sustain or increase defense spending globally, providing long-term growth opportunities for Kopin's technologies.
Strategic Investments and Partnerships: Kopin has secured strategic investments and partnerships, including an $8 million R&D order for Theon International and a $15.4 million color microLED award from the U.S. Army, enhancing its market position and growth potential.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What developments have been made in the neural display product?
A:Kopin demonstrated a first-person viewer, bidirectional, human-in-the-loop microdisplay called neural display, which controlled a drone application with eye movements. This technology is critical for the U.S. government, and Kopin plans to invest in it over the next few years, with a roadmap following their color microLED development.
Q:How should we think about Kopin's quarterly OpEx, especially with Blue Radios behind them?
A:Spending is not expected to change significantly. There are some headwinds in the OpEx area, but the company aims to grow into those expenses.
Q:What is the visibility on Kopin's pipeline and backlog for the next 1-2 years?
A:Kopin has roughly 80% of the backlog required to meet their 2026 plan. They have visibility on three major programs (thermal weapon sight programs, aviation helmet programs, and a medical program) until 2027-2030. They are also working on next-generation programs and new products like Soldier Borne Mission Command, DarkWAVE, and DayVAS to support growth over the next 2-3 years.
Q:What is the status of the Kopin One initiatives and automation?
A:Kopin One is fully integrated, and the fab-lite strategy is almost complete, expected to finish by the end of the year. The first wave of automation was implemented in June, showing efficiency and quality improvements. The second phase will be implemented in December, aiming to add OpEx savings and throughput capability without significant headcount changes.
Q:What caused the decline in military revenue related to pilot aviation heads-up displays?
A:The decline was due to a manufacturing-to-demand timing issue, pushing revenue from this quarter to the next.
Q:Why was SG&A significantly down sequentially, and is this the new run rate?
A:SG&A was down due to one-time events, including a $5.1 million litigation expense and reduced legal fee accruals. This is not the new run rate, and SG&A is expected to normalize.
Q:What is driving confidence in the medical segment for the next two years?
A:The growth of HM DMD, which has signed an agreement with Carl Zeiss for advanced surgical vision systems, and potential new medical products under development. Additionally, there is increased demand for armored vehicle weapon sights and head-mounted systems globally.
Q:What is the outlook for Kopin's European business?
A:Kopin currently has no defense revenue in Europe but has agreements for $8 million in development with Theon for color microLEDs. They expect orders for their DarkWAVE strategy and R&D contracts in Europe, with significant revenue growth starting in 2027-2028, reaching tens of millions.
Q:What is the timeline for revenue from the U.S. Army SBMC program and related initiatives?
A:The SBMC program represents 40% of Kopin's $1 billion opportunity pipeline. Kopin has already received a $15.4 million contract for color microLED development and expects further investments in 2026, with production starting in 2027. The goal is to have their device designed into SBMC applications for production in 2027.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the exact spending changes in OpEx, the precise timeline for automation benefits, and the competitor involved in the U.S. Army SBMC program. Additionally, they did not elaborate on the exact scale of new medical products or the specific timing of European orders in Q4.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Apeiro
Directors
International
UAS
UAV
advantage
ally
award
balance sheet
bond
capital
case
cash position
color microLED
confidence
development production
direction
distraction
drone market
field
footprint
imaging system
income
investor
lawsuit
market investment
night vision
person drone
potential
product weapon
relationship
role
security
selection
tailwind year
time
vision imaging
weapon sight
week
KOPN Transcript
Kopin Corporation (KOPN) Q1 2026 Earnings Call Transcript
Unknown5-12
The earnings call lacked detailed financial performance metrics and did not address key areas like revenue, margins, or cash flow. The call highlighted numerous risks, including demand fluctuations, subsidiary performance, and market conditions, without offering mitigating strategies. The absence of shareholder return discussions further contributes to a negative sentiment. Overall, the lack of clarity and focus on risks suggests a potential negative impact on stock price.
Kopin Corporation (KOPN) Q4 2025 Earnings Call Transcript
Positive3-27
The earnings call reflects strong financial performance with a 15% revenue increase and improved gross margins. Net income turned positive, and cash flow significantly improved. Despite uncertainties in demand and market conditions, the overall sentiment is positive due to robust financial metrics and operational efficiency. The lack of strategic initiatives or shareholder return details tempers the optimism slightly, but the financials suggest a positive short-term stock reaction.
Kopin Corporation (KOPN) Q3 2025 Earnings Call Transcript
Positive11-12
The earnings call highlights strong financial performance with a significant turnaround in net income, reduced SG&A expenses, and a robust cash position. Product development and strategic partnerships, such as with Theon International, indicate potential for future growth. Although there are some uncertainties, like the exact timeline for automation benefits and European orders, the overall sentiment is positive due to the optimistic guidance for future programs and the strategic focus on high-demand sectors like defense and medical.
Kopin Corporation (KOPN) Q2 2025 Earnings Call Transcript
Unknown8-12
The earnings call reveals several concerning factors: a significant revenue decline, dependence on defense spending, and operational transition challenges. Although there's a new partnership with Theon, uncertainties in government budgets have led to reduced customer confidence and delayed orders. The net loss, despite improvement, remains a concern. The Q&A session highlighted missed bookings and unclear management responses. Overall, the negative financial performance and uncertainties outweigh the potential benefits from new contracts and partnerships, indicating a likely negative stock price reaction.
KOPN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
